Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
A revised view of cardiac sodium channel "blockade" in the long-QT syndrome.
Kambouris NG
,
Nuss HB
,
Johns DC
,
Marbán E
,
Tomaselli GF
,
Balser JR
.
???displayArticle.abstract???
Mutations in SCN5A, encoding the cardiac sodium (Na) channel, are linked to a form of the congenital long-QT syndrome (LQT3) that provokes lethal ventricular arrhythmias. These autosomal dominant mutations disrupt Na channel function, inhibiting channel inactivation, thereby causing a sustained ionic current that delays cardiac repolarization. Sodium channel-blocking antiarrhythmics, such as lidocaine, potently inhibit this pathologic Na current (I(Na)) and are being evaluated in patients with LQT3. The mechanism underlying this effect is unknown, although high-affinity "block" of the open Na channel pore has been proposed. Here we report that a recently identified LQT3 mutation (R1623Q) imparts unusual lidocaine sensitivity to the Na channel that is attributable to its altered functional behavior. Studies of lidocaine on individual R1623Q single-channel openings indicate that the open-time distribution is not changed, indicating the drug does not block the open pore as proposed previously. Rather, the mutant channels have a propensity to inactivate without ever opening ("closed-state inactivation"), and lidocaine augments this gating behavior. An allosteric gating model incorporating closed-state inactivation recapitulates the effects of lidocaine on pathologic I(Na). These findings explain the unusual drug sensitivity of R1623Q and provide a general and unanticipated mechanism for understanding how Na channel-blocking agents may suppress the pathologic, sustained Na current induced by LQT3 mutations.
An,
Lidocaine block of LQT-3 mutant human Na+ channels.
1996, Pubmed
An,
Lidocaine block of LQT-3 mutant human Na+ channels.
1996,
Pubmed
Balser,
Local anesthetics as effectors of allosteric gating. Lidocaine effects on inactivation-deficient rat skeletal muscle Na channels.
1996,
Pubmed
,
Xenbase
Balser,
Global parameter optimization for cardiac potassium channel gating models.
1990,
Pubmed
Bennett,
Molecular mechanism for an inherited cardiac arrhythmia.
1995,
Pubmed
,
Xenbase
Bennett,
On the molecular nature of the lidocaine receptor of cardiac Na+ channels. Modification of block by alterations in the alpha-subunit III-IV interdomain.
1995,
Pubmed
,
Xenbase
Chahine,
Sodium channel mutations in paramyotonia congenita uncouple inactivation from activation.
1994,
Pubmed
Chen,
A unique role for the S4 segment of domain 4 in the inactivation of sodium channels.
1996,
Pubmed
,
Xenbase
Clancy,
Linking a genetic defect to its cellular phenotype in a cardiac arrhythmia.
1999,
Pubmed
Dumaine,
Multiple mechanisms of Na+ channel--linked long-QT syndrome.
1996,
Pubmed
,
Xenbase
Fan,
Two human paramyotonia congenita mutations have opposite effects on lidocaine block of Na+ channels expressed in a mammalian cell line.
1996,
Pubmed
Filatov,
Inactivation and secondary structure in the D4/S4-5 region of the SkM1 sodium channel.
1998,
Pubmed
Hamill,
Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches.
1981,
Pubmed
Horn,
Sodium channels need not open before they inactivate.
1981,
Pubmed
Ji,
Paramyotonia congenita mutations reveal different roles for segments S3 and S4 of domain D4 in hSkM1 sodium channel gating.
1996,
Pubmed
Johns,
Suppression of neuronal and cardiac transient outward currents by viral gene transfer of dominant-negative Kv4.2 constructs.
1997,
Pubmed
Kambouris,
Phenotypic characterization of a novel long-QT syndrome mutation (R1623Q) in the cardiac sodium channel.
1998,
Pubmed
,
Xenbase
Lawrence,
Sodium channel inactivation from resting states in guinea-pig ventricular myocytes.
1991,
Pubmed
Lerche,
Role in fast inactivation of the IV/S4-S5 loop of the human muscle Na+ channel probed by cysteine mutagenesis.
1997,
Pubmed
Makita,
A de novo missense mutation of human cardiac Na+ channel exhibiting novel molecular mechanisms of long QT syndrome.
1998,
Pubmed
,
Xenbase
McPhee,
A critical role for the S4-S5 intracellular loop in domain IV of the sodium channel alpha-subunit in fast inactivation.
1998,
Pubmed
,
Xenbase
Ragsdale,
Common molecular determinants of local anesthetic, antiarrhythmic, and anticonvulsant block of voltage-gated Na+ channels.
1996,
Pubmed
Ragsdale,
Molecular determinants of state-dependent block of Na+ channels by local anesthetics.
1994,
Pubmed
,
Xenbase
Scanley,
Kinetic analysis of single sodium channels from canine cardiac Purkinje cells.
1990,
Pubmed
Schwartz,
Long QT syndrome patients with mutations of the SCN5A and HERG genes have differential responses to Na+ channel blockade and to increases in heart rate. Implications for gene-specific therapy.
1995,
Pubmed
Shimizu,
Sodium channel block with mexiletine is effective in reducing dispersion of repolarization and preventing torsade des pointes in LQT2 and LQT3 models of the long-QT syndrome.
1997,
Pubmed
Smith,
Interaction between the sodium channel inactivation linker and domain III S4-S5.
1997,
Pubmed
,
Xenbase
Stühmer,
Structural parts involved in activation and inactivation of the sodium channel.
1989,
Pubmed
,
Xenbase
Sunami,
Sodium channel selectivity filter regulates antiarrhythmic drug binding.
1997,
Pubmed
,
Xenbase
Tang,
Glutamine substitution at alanine1649 in the S4-S5 cytoplasmic loop of domain 4 removes the voltage sensitivity of fast inactivation in the human heart sodium channel.
1998,
Pubmed
Vedantham,
The position of the fast-inactivation gate during lidocaine block of voltage-gated Na+ channels.
1999,
Pubmed
,
Xenbase
Wang,
Pharmacological targeting of long QT mutant sodium channels.
1997,
Pubmed
Wang,
Characterization of human cardiac Na+ channel mutations in the congenital long QT syndrome.
1996,
Pubmed
Weiner,
A method for the site-directed mono- and multi-mutagenesis of double-stranded DNA.
1993,
Pubmed
West,
A cluster of hydrophobic amino acid residues required for fast Na(+)-channel inactivation.
1992,
Pubmed
,
Xenbase
Yamagishi,
A de novo missense mutation (R1623Q) of the SCN5A gene in a Japanese girl with sporadic long QT sydrome. Mutations in brief no. 140. Online.
1998,
Pubmed
Yue,
Two molecular transitions influence cardiac sodium channel gating.
1989,
Pubmed
